Lilly's SVP of Talent said diverse backgrounds, skills and perspectives "fuel" innovation and "strengthen the understanding ...

Green chemistry isn’t always top of mind for industrial drug discovery chemists. This 4-point plan can get it there ...

From company officials to environmental advocates, here is a look at the key players making headlines related to the xAI project in Memphis.

Eight Philadelphia-area companies made this year’s Fortune 500 list, which ranks the country’s largest businesses by revenue.

In this article, we look at two stocks, one from the chemicals sector and another from the pharma sector, recommended by the Trade Brains Portal to buy for an upside potential of more than 22%. We ...

As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...

This Small-cap Pharma Stock, engaged in the research and development of innovative pharmaceutical products, focusing on therapies for unmet medical needs, hit a 20 percent lower circuit after the ...

Dollar Tree remains optimistic about its long-term prospects, but tariffs will pressure the discount-retail chain in the near term. The combined entity will be worth roughly $19 billion, including ...

UnitedHealth Group, Apple and CVS Health also ranked among Fortune’s top five U.S. corporations by revenue for the 2024 fiscal year.

Trump and his aides have repeatedly shifted their stance on tariffs in the weeks since the president’s “Liberation Day” ...

Arrowhead Pharmaceuticals, Snowflake, Dover and Fluor are each in focus on today's edition of "Mad Money Lightning Round." ...

Eli Lilly's portfolio, both within and outside its core area, makes the stock attractive. However, a recent move Eli Lilly made reveals an underrated reason why the stock has attractive prospects.